Skip to content

    Zensar Tech.

    ZENSARTECH
    Information Technology·23 Jan 2026
    Management Summary

    Zensar Technologies reported a modest yet resilient Q3 FY26 with revenue of $160.5 million, growing 2.2% YoY in reported currency, despite sequential degrowth. Profitability metrics were strong, with EBITDA at 17.4% (up 200 bps QoQ) and dollar profit growth of 18.2% YoY, driven by offshore mix and operational efficiencies. The company maintained a healthy order book of $180.2 million and strong cash position, while navigating continued softness in the TMT and Life Sciences verticals.

    Highlights

    6
    • Revenue of $160.5 million, up 2.2% YoY in reported currency and 1.3% in constant currency.

    • EBITDA improved to 17.4%, a sequential growth of 200 basis points, driven by improved offshore mix and operational efficiencies.

    • Order book reached $180.2 million, reflecting a sequential growth of 13.6% and a book-to-bill ratio of 1.12.

    • Net cash and cash equivalents improved to $322.4 million, a sequential growth of $29.4 million, with DSO at 71 days.

    • Voluntary attrition improved to 9.5%, marking the fourth successive quarter below 10%, demonstrating strong talent retention.

    • Profit growth in dollar terms was 18.2% year-over-year, and diluted EPS grew 9.4% QoQ to INR 8.7 per share.

    Concerns

    4
    • Revenue degrowth of 1.4% sequentially in reported terms and 1.3% in constant currency.

    • The Telecommunication, Media and Technology (TMT) vertical continues to be a stress area, declining 11.6% YoY, with management expecting it to remain flat at best.

    • Life Sciences vertical experienced continued headwinds and client consolidation, with some impact expected in Q4.

    • Impact of furloughs (1.0%) and ESOP costs (0.9%) partially offset EBITDA expansion drivers.

    What Changed3

    vs Q4 FY26

    Guidance items6 → 2 (-4)Risks discussed5 → 4 (-1)Q&A highlights6 → 8 (+2)

    Key financials

    Single quarter

    10 metrics
    1. 01Revenue160.5 Mn+2.2%YoY
    2. 02Revenue (Constant Currency)+1.3%YoY
    3. 03EBITDA Margin17.4%+2%QoQ
    4. 04PAT Margin13.9%
    5. 05Diluted EPS₹8.7+9.4%QoQ

    Segment breakdown

    Banking and Financial Services
    12.2% Revenue Growth (YoY Reported)
    Healthcare and Life Sciences
    5.2% Revenue Growth (YoY Reported)60 Mn Vertical Size
    Manufacturing, Consumer Services
    -2.7% Revenue Growth (YoY Reported)
    Telecommunication, Media and Technology
    -11.6% Revenue Growth (YoY Reported)10% Share of Revenue
    Service Lines (Share of Revenue)
    69% Share of Revenue2.2% YoY Increase
    Cloud Infrastructure and Security services
    10.9% Revenue Growth (YoY Reported)
    Data Engineering and Analytics
    13.1% Revenue Growth (YoY Reported)
    Products and platforms (including CMO services)
    3% Revenue Growth (YoY Reported)
    Enterprise Application services
    -3.6% Revenue Growth (YoY Reported)
    List

    Order Book

    high confidence

    Total Value

    USD 180.2 million

    as of 2025-12-31

    quantified
    13.6% QoQ

    Inflow this qtr

    USD 180.2 million

    Composition

    AI Influenced(other)
    20.0%
    Existing New (EN) and New New (NN)(contract type)
    25.0%

    Pipeline

    deal pipeline tcv

    Pipeline has fairly strong visibility

    "Order book is strong and has been in a similar range over the last four quarters, with a significant portion influenced by AI."

    Source:
    Prepared remarks

    Capital allocation

    2
    high confidence
    CategoryHeadline
    Dividend

    ₹2.4/share (interim)

    Liquidity

    Cash USD 322.4 million

    Net cash and cash equivalents positions improved to $322.4 million, sequential growth of $29.4 million.

    Guidance & targets

    1
    CategoryTargetPriority
    Profitability
    EBITDA Margin
    mid-teen
    High

    Revenue Reflection of Volume Growth

    next quarter (Q4 FY26)
    Current1.3% CC YoY, -1.3% CC QoQ
    TargetImproved sequential revenue growth

    Why it matters

    To verify if healthy volume growth and higher working days translate into improved revenue numbers, signaling a growth turnaround.

    I think next quarter, if this volume growth is, I think it is, sustainable along with the higher number of working days that we see, we should start seeing a reflection in revenue numbers also.

    How to verify

    key_financials.metrics[label='Revenue (Constant Currency)'].qoq_growth

    Risks & concerns

    4
    RiskSeverity

    TMT Vertical Weakness

    The Telecommunication, Media and Technology (TMT) vertical continues to be a stress area, declining 11.6% YoY, with management expecting it to remain flat at best or even see further downside.Management acknowledged

    medium

    Life Sciences Headwinds

    The Life Sciences vertical experienced continued headwinds due to client consolidation, with some impact expected in Q4.Management acknowledged

    medium

    Seasonal Softness and Furloughs

    Q3 reflected expected seasonal softness, coupled with furloughs, which moderated revenue growth and impacted EBITDA by 1.0%.Management acknowledged

    low

    Non-recurring Operational Efficiencies

    Some benefits from leave utilization and other operational efficiencies that contributed to margin expansion in Q3 may not recur in the next quarter.Management acknowledged

    low

    Q&A highlights

    8

    “When we say 20% of our order book is AI influenced, we believe that we believe in tracking that only EN and NN can be ordered can be AI influenced. We do not believe that renewals can be AI influenced.”

    Clarifies the company's conservative and specific methodology for reporting AI-influenced deals, distinguishing it from potentially broader peer definitions.

    asked by Nitin Padmanabhan

    2 min read6 chapters

    Detailed Narrative

    01

    Q3 FY26 Performance Overview and Volume Growth

    Zensar Technologies reported Q3 FY26 revenue of $160.5 million, reflecting a 2.2% YoY growth in reported currency and 1.3% in constant currency. However, the company experienced a sequential degrowth of 1.4% (reported) and 1.3% (constant currency). Despite this, the quarter saw healthy volume growth, predominantly driven from offshore, with overall volume growth at 1.7% and offshore volume growth at 3.1%. Management anticipates that sustainable volume growth, coupled with higher working days, should lead to a reflection in revenue numbers next quarter.

    02

    Robust Profitability and Margin Expansion Drivers

    The company achieved strong profitability, with Gross Profit improving to 33.7% (up 270 basis points QoQ) and EBITDA expanding to 17.4% (up 200 basis points QoQ). This margin expansion was primarily driven by a 1.4% improvement in offshore effort mix, a 1.0% benefit from leave utilization, and 0.7% from other operational efficiencies. These gains were partially offset by a 1.0% impact from furloughs and 0.9% from ESOP costs. Management emphasized a long-term commitment to mid-teen EBITDA margins and double-digit profit growth, with dollar profit growth at 18.2% YoY and EPS growth at 24.1% YoY.

    03

    Order Book Strength and AI Integration

    The order book for Q3 FY26 stood at $180.2 million, representing a sequential growth of 13.6%, with a book-to-bill ratio of 1.12. Zensar reported that 20% of its order book is AI-influenced, specifically counting new and existing new deals. The company has made strategic investments in AI, with nearly 60% of its workforce AI certified and over 7,300 employees impacted by its Ignite AI Academy, demonstrating a commitment to becoming an AI-native technology services company.

    04

    Vertical Performance: Strengths and Headwinds

    While Banking and Financial Services grew robustly at 12.2% YoY and Healthcare and Life Sciences at 5.2% YoY, the Telecommunication, Media and Technology (TMT) vertical continued to be a significant stress area, declining 11.6% YoY and now representing less than 10% of total revenue. Management expressed a cautious outlook for TMT, expecting it to remain flat at best. Life Sciences also faced continued headwinds due to client consolidation, with some impact anticipated in Q4.

    05

    Capital Allocation and Shareholder Value Focus

    Zensar maintained a strong financial position with net cash and cash equivalents of $322.4 million, a sequential increase of $29.4 million. The Board declared an interim dividend of INR 2.4 per share. Management reiterated its focus on maximizing shareholder value through profitable growth and is actively evaluating strategic inorganic opportunities that are accretive to the bottom line, rather than pursuing revenue growth at any cost.

    06

    Operational Efficiency and Talent Management

    Operational efficiency was evident with utilization at 83.5%, despite a 130 basis points QoQ decline due to seasonal furloughs. Voluntary attrition improved to 9.5%, marking the fourth consecutive quarter below 10%, reflecting strong talent retention. The company continues to invest in capability enrichment, particularly in AI, with significant employee training initiatives.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.